Longevity & ImmuneGrade B
Thymosin Alpha 1
Also known as Zadaxin
An immune-modulating peptide used internationally for hepatitis, sepsis, and adjunct cancer care.
- Regulatory status
- Approved in 30+ countries; not FDA approved
- Half-life
- ~2 hours
- Route
- Subcutaneous
- Evidence
- Limited human trials or approved outside the US
Mechanism of action
Enhances T-cell maturation and dendritic cell function via TLR signaling.
Studied and reported uses
- Immune support
- Chronic viral infection adjunct
- Sepsis adjunct
Dosing information
Clinical range1.6 mg twice weekly
Ranges are reported from literature and clinical labeling for reference only. They are not a dosing recommendation.
Side effects
- Injection-site reaction
- Transient flu-like symptoms
Research evidence
Sepsis RCT
Improved immune markers and trend toward lower mortality.